Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose intranasal dexmedetomidine before cesarean section
ChiCTR2500109021Phase 4Not yet recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postpartum depression (PPD), acute postoperative pain, postanesthetic shivering (PAS) and 2 more (2 arms), sponsored by Maternal and Child Health Hospital of Hubei Province. Primary endpoints: Visual pain score, Apgar score and 5 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postpartum depression (PPD)acute postoperative painpostanesthetic shivering (PAS)postoperative nausea and vomiting (PONV)Cardiovascular collapse
Beyond the preview
Go deeper on ChiCTR2500109021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109021.